Suchergebnisse - "Slomovitz, Brian M"

PubPharm (144)

1

Vulvar cancer management and wrangling recurrent disease : A report from the society of gynecologic oncology journal club

enthalten in: Gynecologic oncology reports | 2023

von Parker, J. | Yoshida, E. | Gien, L. | +2

2

Low-grade serous ovarian cancer : expert consensus report on the state of the science

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Grisham, R. | Slomovitz, B. | Andrews, N. | +16

CommentIn: Int J Gynecol Cancer. 2023 Sep 4;33(9):1345-1346. - PMID 37666542

3

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

enthalten in: The New England journal of medicine | 2023

von Mirza, M. | Chase, D. | Slomovitz, B. | +129

CommentIn: Nat Rev Clin Oncol. 2023 Jun;20(6):353. - PMID 37024681

4

Immunotherapy in endometrial cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Mahdi, H. | Chelariu-Raicu, A. | Slomovitz, B.

5

Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer : Phase IIb CONCERTO Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Lee, J. | Moore, R. | Ghamande, S. | +12

6

Efficacy of niraparib by time of surgery and postoperative residual disease status : A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

enthalten in: Gynecologic oncology | 2022

von O'Cearbhaill, R. | Pérez-Fidalgo, J. | Monk, B. | +22

7

The vaginal microbiome is associated with endometrial cancer grade and histology

enthalten in: Cancer research communications | 2022

von Hakimjavadi, H. | George, S. | Taub, M. | +11

8

A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma : A GOG Foundation study

enthalten in: Gynecologic oncology | 2022

von Slomovitz, B. | Filiaci, V. | Walker, J. | +9

9

Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer : Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I

enthalten in: JCO precision oncology | 2022

von Krop, I. | Jegede, O. | Grilley-Olson, J. | +22

ErratumIn: JCO Precis Oncol. 2022 Mar;6:e2200116. - PMID 35294227

10

Changing treatments paradigms and role of immunotherapy in recurrent endometrial cancer

enthalten in: Current opinion in obstetrics & gynecology | 2022

von Chelariu-Raicu, A. | Mahdi, H. | Slomovitz, B.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]